AFFLUENT MEDICAL (Germany) Performance
| 0JZ Stock | 1.39 0.01 0.72% |
The firm shows a Beta (market volatility) of 0.4, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, AFFLUENT MEDICAL's returns are expected to increase less than the market. However, during the bear market, the loss of holding AFFLUENT MEDICAL is expected to be smaller as well. At this point, AFFLUENT MEDICAL SAS has a negative expected return of -0.14%. Please make sure to confirm AFFLUENT MEDICAL's total risk alpha, potential upside, and the relationship between the standard deviation and maximum drawdown , to decide if AFFLUENT MEDICAL SAS performance from the past will be repeated at some future date.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days AFFLUENT MEDICAL SAS has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest uncertain performance, the Stock's basic indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders. ...more
AFFLUENT |
AFFLUENT MEDICAL Relative Risk vs. Return Landscape
If you would invest 160.00 in AFFLUENT MEDICAL SAS on October 10, 2024 and sell it today you would lose (21.00) from holding AFFLUENT MEDICAL SAS or give up 13.12% of portfolio value over 90 days. AFFLUENT MEDICAL SAS is currently producing negative expected returns and takes up 4.2643% volatility of returns over 90 trading days. Put another way, 37% of traded stocks are less volatile than AFFLUENT, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
AFFLUENT MEDICAL Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for AFFLUENT MEDICAL's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as AFFLUENT MEDICAL SAS, and traders can use it to determine the average amount a AFFLUENT MEDICAL's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0339
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | 0JZ |
Estimated Market Risk
| 4.26 actual daily | 37 63% of assets are more volatile |
Expected Return
| -0.14 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.03 actual daily | 0 Most of other assets perform better |
Based on monthly moving average AFFLUENT MEDICAL is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of AFFLUENT MEDICAL by adding AFFLUENT MEDICAL to a well-diversified portfolio.
Things to note about AFFLUENT MEDICAL SAS performance evaluation
Checking the ongoing alerts about AFFLUENT MEDICAL for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for AFFLUENT MEDICAL SAS help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| AFFLUENT MEDICAL SAS generated a negative expected return over the last 90 days | |
| AFFLUENT MEDICAL SAS may become a speculative penny stock | |
| AFFLUENT MEDICAL SAS has high historical volatility and very poor performance |
- Analyzing AFFLUENT MEDICAL's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether AFFLUENT MEDICAL's stock is overvalued or undervalued compared to its peers.
- Examining AFFLUENT MEDICAL's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating AFFLUENT MEDICAL's management team can have a significant impact on its success or failure. Reviewing the track record and experience of AFFLUENT MEDICAL's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of AFFLUENT MEDICAL's stock. These opinions can provide insight into AFFLUENT MEDICAL's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for AFFLUENT Stock analysis
When running AFFLUENT MEDICAL's price analysis, check to measure AFFLUENT MEDICAL's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AFFLUENT MEDICAL is operating at the current time. Most of AFFLUENT MEDICAL's value examination focuses on studying past and present price action to predict the probability of AFFLUENT MEDICAL's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AFFLUENT MEDICAL's price. Additionally, you may evaluate how the addition of AFFLUENT MEDICAL to your portfolios can decrease your overall portfolio volatility.
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |